Treatment Outcomes

1
Treatment Outcomes
5-yr Estimate (95 CI) 8-yr Estimate (95 CI) Log-Rank P-value
Progression-Free Survival Progression-Free Survival Progression-Free Survival 0.04
FL-3 with rituximab 65 (5077) 45 (2365)
FL-3 without rituximab 42 (3450) 33 (2641)
DLBCL with rituximab 53 (4758) 47 (4054)
Overall Survival Overall Survival Overall Survival 0.06
FL-3 with rituximab 85 (7292) 71 (5482)
FL-3 without rituximab 68 (5974) 54 (4662)
DLBCL with rituximab 64 (5869) 56 (4863)
FL-3follicular lymphoma, grade 3 DLBCLdiffuse large B-cell lymphoma FL-3follicular lymphoma, grade 3 DLBCLdiffuse large B-cell lymphoma FL-3follicular lymphoma, grade 3 DLBCLdiffuse large B-cell lymphoma FL-3follicular lymphoma, grade 3 DLBCLdiffuse large B-cell lymphoma
2810